Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Noninvasive Blood Glucose Test Evaluated for Accuracy

By LabMedica International staff writers
Posted on 23 Oct 2018
For those living with diabetes, monitoring blood glucose accurately is necessary to prevent diabetes-related complications such as heart attacks, blindness and coma. More...
Optical monitoring of blood glucose levels for non-invasive diagnosis is growing.

Recent efforts in this direction have been inclined towards reducing the requirement of calibration framework. Scientists have evaluated the accuracy of new technology to monitor blood glucose levels without needles or a finger prick. Early results show that the noninvasive technology measures blood glucose levels as effectively as a finger prick test without drawing blood.

A team of scientists from the Massachusetts Institute of Technology (Cambridge, MA, USA) and the University of Missouri-Columbia (Columbia, MO, USA) measured the blood glucose levels of 20 healthy, non-diabetic adults prior to drinking a glucose-rich beverage. Blood glucose levels were then measured in intervals over the next 160 minutes using three methods: spectroscopy, intra-venous blood test and finger prick. The tests are designed to determine how much glucose remains in the blood and if a patient's insulin-regulating mechanisms are working effectively. They found that spectroscopy predicted glucose values as accurately as a finger prick test.

The device uses a technique called Raman spectroscopy to measure the chemical composition of skin and extract the amount of glucose out of other skin compartments. A fiber optic cable attached to a wristband passes laser light onto the skin to detect different components in the skin, such as fat tissue, protein, collagen and glucose molecules. The shifts in wavelengths associated with glucose present in the blood create a sort of molecular fingerprint that can be used to determine glucose levels.

Jeon Woong Kang, PhD, a lead co-author of the study said, “We know that handheld skin prick tests are not always accurate and may be uncomfortable for patients. The gold standard is intravenous blood testing, but frequent blood draws may not be an option for many patients. We were pleased to find that our initial results show Raman spectroscopy can measure glucose levels that are comparable to the finger stick devices. We hope that we can refine this method to be a noninvasive continuous glucose monitoring sensor.” The study was published in the October 2018 issue of the journal Analytical and Bioanalytical Chemistry.

Related Links:
Massachusetts Institute of Technology
University of Missouri-Columbia


Gold Member
Quantitative POC Immunoassay Analyzer
EASY READER+
3-Part Differential Hematology Analyzer
Swelab Alfa Plus Sampler
New
Rapid Test Reader
DIA5000
New
Gold Member
Blood Gas Analyzer
Stat Profile pHOx
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








DIASOURCE (A Biovendor Company)

Channels

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: A simple blood test could replace surgical biopsies for early detecion of heart transplant rejection (Photo courtesy of Shutterstock)

Blood Test Detects Organ Rejection in Heart Transplant Patients

Following a heart transplant, patients are required to undergo surgical biopsies so that physicians can assess the possibility of organ rejection. Rejection happens when the recipient’s immune system identifies... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.